Anzeige
Mehr »
Samstag, 19.07.2025 - Börsentäglich über 12.000 News
Foremost Clean Energy: Auf dem Weg zu großen Entdeckungen im Saudi-Arabien des Urans
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P7ZC | ISIN: SE0014401121 | Ticker-Symbol: 52Q
Frankfurt
17.07.25 | 09:19
0,001 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MAGNASENSE AB Chart 1 Jahr
5-Tage-Chart
MAGNASENSE AB 5-Tage-Chart

Aktuelle News zur MAGNASENSE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoMagnasense AB: The Letter of Intent with Subgen AI Limited regarding reverse takeover has been extended61Magnasense AB ("Magnasense" or the "Company") announces a further extension of the Letter of Intent regarding a potential reverse takeover (the "Transaction") with Subgen AI Limited ("Subgen"), a UK-based...
► Artikel lesen
MoMagnasense AB: Magnasense AB files appeal against decision by Swedish Financial Supervisory Authority44Magnasense AB has today filed an appeal with the Administrative Court in Stockholm against the decision by the Swedish Financial Supervisory Authority (Finansinspektionen) dated 25 June 2025 regarding...
► Artikel lesen
07.07.Magnasense AB: Vasiliki Fragkou Resigns from her position as Chief Operating Officer of Magnasense AB and as a director of AegirBio UK Ltd.59Magnasense/AegirBio UK Ltd. announces that Vasiliki Fragkou has officially stepped down from her position. We would like to sincerely thank Vasiliki for her dedication and contributions during her time...
► Artikel lesen
29.06.Magnasense AB: The Letter of Intent with Subgen AI Limited regarding reverse takeover has been extended73Magnasense AB ("Magnasense" or the "Company") announces an extension of the Letter of Intent regarding a potential reverse takeover (the "Transaction") with Subgen AI Limited ("Subgen"), a UK-based...
► Artikel lesen
25.06.Magnasense AB: Magnasense AB receives decision on penalty fee from the Swedish Financial Supervisory Authority164The Swedish Financial Supervisory Authority ("SFSA") has decided to impose a fine of SEK 12 million on Magnasense AB ("Magnasense" or the "Company") for violations of MAR. On 14 April 2023, the SFSA...
► Artikel lesen
10.06.Magnasense AB receives observation status136Today, June 10, 2025, Magnasense AB (the "Company") issued a press release with information that the Company has signed a letter of intent regarding a reverse takeover of SUBGEN AI LIMITED. According...
► Artikel lesen
10.06.Magnasense AB: Magnasense enters into Letter of Intent with Subgen AI Limited regarding a reverse takeover116Magnasense AB ("Magnasense" or the "Company") announces today that the Company has entered into a non-binding letter of intent ("Letter of Intent") with SUBGEN AI LIMITED, registration number 15374966...
► Artikel lesen
MAGNASENSE Aktie jetzt für 0€ handeln
05.05.Magnasense AB: Interview with Magnasense: Key Insights from the RADx Initiative190Q: Could you tell us about the primary goal of the RADx initiative and the role Magnasense played in it? A: The RADx initiative aimed to develop a Multiplex Diagnostic Platform that could detect COVID-19...
► Artikel lesen
28.04.Magnasense AB: Magnasense AB Targets Gum Disease Market with Groundbreaking Diagnostic Technology - Capital Raise Underway to Accelerate Entry in High-Value Underserved Market112Magnasense AB, an innovator in smart diagnostics, is preparing to enter one of the largest yet underserved healthcare markets: periodontal (gum) disease. Magnasense is currently advancing its digital...
► Artikel lesen
24.04.Magnasense AB: Overview of the Rights Issue in Magnasense AB131NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND...
► Artikel lesen
22.04.Magnasense AB: Magnasense AB Develops Innovative Saliva Test for Gum Disease Detection141Rights Issue to Support Development of Groundbreaking Diagnostic Tool Magnasense AB, a company specializing in rapid diagnostics, is in the process of developing a non-invasive saliva-based test designed...
► Artikel lesen
22.04.Magnasense AB: Magnasense AB publishes information memorandum due to upcoming rights issue of units153NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND...
► Artikel lesen
17.04.XFRA CAPITAL ADJUSTMENT INFORMATION - 17.04.2025456Das Instrument 52Q SE0014401121 MAGNASENSE AB EQUITY wird ex Kapitalmassnahme gehandelt am 17.04.2025 The instrument 52Q SE0014401121 MAGNASENSE AB EQUITY is traded ex capital adjustment on 17.04.2025Das...
► Artikel lesen
10.04.Magnasense AB: Magnasense resolves on the previously announced rights issue of units of a minimum of approx. MSEK 15 and a maximum of approx. MSEK 26.7 to develop saliva-based diagnostics as an alternative to blood testing86NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND...
► Artikel lesen
05.03.Magnasense AB: Magnasense Interim Report October - December 2024143"We are expanding our product capabilities as well as advancing solutions that are directly aligned with our professional market focus in oral health." Marco Witteveen, CEO of Magnasense AB October...
► Artikel lesen
28.02.XFRA CAPITAL ADJUSTMENT INFORMATION - 28.02.2025241Das Instrument 7OK MHY641771016 OKEANIS ECO TANK. DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 28.02.2025 und ex Kapitalmassnahme am 03.03.2025 The instrument 7OK MHY641771016 OKEANIS ECO TANK....
► Artikel lesen
15.11.24Magnasense AB: Magnasense Interim Report July - September 2024260"We are expanding our product capabilities as well as advancing solutions that are directly aligned with our professional market focus in oral health." Marco Witteveen, CEO of Magnasense AB July - October...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1